triparanol has been researched along with Coronary Artery Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CHOBANIAN, A; HOLLANDER, W | 1 |
CORCORAN, AC | 1 |
CORCORAN, AC; CUTURELLI, R; ZIMMERMAN, HA | 1 |
CHOBANIAN, AV; HOLLANDER, W; WILKINS, RW | 2 |
DAVIS, FW | 1 |
RUSSEK, HI | 1 |
7 other study(ies) available for triparanol and Coronary Artery Disease
Article | Year |
---|---|
The effects of an inhibitor of cholesterol biosynthesis triparanol (MER-29), in subjects with and without coronary artery disease.
Topics: Alcohols; Cholesterol; Coronary Artery Disease; Coronary Disease; Ethanol; Hypertension; Triparanol | 1959 |
Coronary atherosclerosis status of MER-29 (triparanol).
Topics: Anticholesteremic Agents; Atherosclerosis; Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Humans; Triparanol | 1961 |
Note on MER-29 in arteriosclerotic heart disease.
Topics: Anti-Arrhythmia Agents; Anticholesteremic Agents; Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Humans; Triparanol | 1960 |
The cholesterol lowering effects of triparanol (MER-29) in subjects with and without coronary artery disease.
Topics: Anti-Arrhythmia Agents; Anticholesteremic Agents; Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Diuretics; Humans; Triparanol | 1960 |
The effects of triparanol (MER-29) in subjects with and without coronary artery disease.
Topics: Anticholesteremic Agents; Cholesterol; Coronary Artery Disease; Coronary Disease; Heart; Hematologic Diseases; Humans; Triparanol | 1960 |
Triparanol therapy in coronary heart disease. A preliminary report.
Topics: Anticholesteremic Agents; Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Humans; Triparanol | 1962 |
Effect of MER-29 on the pain experience and the electrocardiographic response to standard exercise in patients with coronary artery disease.
Topics: Anticholesteremic Agents; Coronary Artery Disease; Coronary Disease; Electrocardiography; Exercise; Humans; Pain; Triparanol | 1960 |